Corporate Board Profile
| Filing Date | Source Excerpt |
|---|---|
| 2013-07-12 | Mr. Collins served as the President, Chief Executive Officer, and a director of Pernix Therapeutics Holdings, Inc. |
| 2014-04-17 | Mr. Collins has served as Chief Strategy Officer of Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company. |
| 2015-04-30 | Mr. Collins has served as Chief Strategy Officer of Pernix Therapeutics Holdings, Inc. from May 2013 until April 2014. |
| 2016-04-28 | Mr. Collins has served as Chief Executive Officer of Fortis BioPharma since June 2015. |
| 2017-04-25 | Mr. Collins has served as Chief Executive Officer of Fortis BioPharma since June 2015. |
| 2018-04-27 | Mr. Collins has served as Chief Executive Officer of Fortis BioPharma since June 2015. |
| 2019-04-30 | Cooper C. Collins has served as a director of our company since February 2012. |
| 2020-05-04 | Cooper C. Collins has served as a director of our company since February 2012. |
| 2021-04-14 | Cooper C. Collins has served as a director of our company since February 2012. |
| 2023-05-17 | Cooper C. Collins has served as a director of our Company since February 2012. Mr. Collins has served as Chief Executive Officer of Fortis BioPharma LLC since June 2015. |
| 2024-10-25 | Cooper C. Collins has served as a director of our Company since February 2012. |
Data sourced from SEC filings. Last updated: 2025-04-15